Aoxin Q&M Dental Group (SGX:1D4
) announced that it has submitted an application to the Singapore Exchange on June 26 on the proposed transfer of its current listing from Catalist to Mainboard.
In the June 26 announcement, Aoxin states that it has achieved a consolidated profit before tax of around RMB8.4 million ($1.6 million) for the financial year ended Dec 31, 2025 (FY2025).
After excluding certain non-recurring share of losses attributable to Acumen Diagnostics, an associate in which Aoxin holds 49% equity interests, Aoxin’s underlying businesses would have recorded profit before tax of around RMB2.7 million, RMB7.7 million and RMB8.4 million for FY2023, FY2024 and FY2025 respectively.
Aoxin explains that the earnings recorded in the past three financial years demonstrates the profitability of its core businesses and a consistent improvement in its underlying financial performance.
“Based on Aoxin’s current market position, financial performance, stage of growth and relative stability, the directors are of the opinion that the proposed transfer is timely and appropriate,” reads the June 26 announcement.
Aoxin says that the proposed transfer will provide the company with a wider platform and greater opportunities for future fund raising, and give the company access to a larger and more diverse investor market.
See also: Soup Holdings issues profit warning after paying pre-termination fee of $384,000
Shares of Aoxin closed down 1 cent, or 4.17% lower at 23 cents on June 26.
